EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma

Nicholas Kesby iD, Robert Mechera, Talia Fuchs, Alexander Papachristos, Matti Gild, Venessa Tsang, Roderick Clifton-Bligh, Bruce Robinson, Mark Sywak, Stan Sidhu, Angela Chou, Anthony J Gill und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgad173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Nicholas Kesby und 12 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Surgery Unit, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Medullary, Peptide Hormones, Bone Density Conservation Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Institute NSW Early Career Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Management of sporadic medullary thyroid microcarcinoma smaller than 1 cm (micro-MTC) is controversial because of conflicting reports of prognosis. As these cancers are often diagnosed incidentally, they pose a management challenge when deciding on further treatment and follow-up.

Objective

We report the outcomes of surgically managed sporadic micro-MTC in a specialist endocrine surgery and endocrinology unit and identify associations for recurrence and disease-specific survival in this population.

Methods

Micro-MTCs were identified from a prospectively maintained surgery database, and slides were reviewed to determine pathological grade. The primary end points were recurrence, time to recurrence and disease-specific survival. Prognostic factors assessed included size, grade, lymph node metastasis (LNM), and postoperative calcitonin.

Results

From 1995 to 2022, 64 patients were diagnosed with micro-MTC with 22 excluded because of hereditary disease. The included patients had a median age of 60 years, tumor size of 4 mm, and 28 (67%) were female. The diagnosis was incidental in 36 (86%) with 4 (10%) being high grade, 5 (12%) having LNM and 9 (21%) having elevated postoperative calcitonin. Over a 6.6-year median follow-up, 5 (12%) developed recurrence and 3 (7%) died of MTC. High grade and LNM were associated with 10-year survival estimates of 75% vs 100% for low grade and no LNM (hazard ratio = 831; P < .01). High grade, LNM, and increased calcitonin were associated with recurrence (P < .01). Tumor size and type of surgery were not statistically significantly associated with recurrence or survival. No patients with low grade micro-MTC and normal postoperative calcitonin developed recurrence.

Conclusion

Most sporadic micro-MTCs are detected incidentally and are generally associated with good outcomes. Size is not significantly associated with outcomes. Using grade, LNM, and postoperative calcitonin allows for the identification of patients at risk of recurrence to personalize management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, MedullaryPeptide HormonesBone Density Conservation AgentsHumansFemaleMiddle AgedMaleCalcitoninThyroidectomyLymph Node ExcisionPrognosisCalcium-Regulating Hormones and AgentsRetrospective Studies

Stichwörter der Autor:innen

medullary thyroid cancermedullary thyroid microcarcinomaoutcomessurgerytumor grade

Substanzen

CalcitoninPeptide HormonesBone Density Conservation AgentsCalcium-Regulating Hormones and Agents

Autor:innen und Institutionen

  • Endocrine Surgery Unit, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia.
  • The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW 2010, Australia.
  • Clarunis, University Hospital Basel, Basel, Basel-Stadt 4031, Switzerland.
  • NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
  • Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2065, Australia.
  • Department of Endocrinology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia.

ORCID-Profile: Nicholas Kesby, Anthony Glover

Förderung

  • Cancer Institute NSW Early Career Fellowship

Zitieren

APA

Kesby, N., Mechera, R., Fuchs, T., Papachristos, A., Gild, M., Tsang, V., Clifton-Bligh, R., Robinson, B., Sywak, M., Sidhu, S., Chou, A., Gill, A. J., & Glover, A. (2023). Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad173

Vancouver

Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, et al. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad173

BibTeX
@article{Kesby2023,
  author = {Kesby, Nicholas and Mechera, Robert and Fuchs, Talia and Papachristos, Alexander and Gild, Matti and Tsang, Venessa and Clifton-Bligh, Roderick and Robinson, Bruce and Sywak, Mark and Sidhu, Stan and Chou, Angela and Gill, Anthony J and Glover, Anthony},
  title = {Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgad173}
}
Kostenlos starten →